[Effect of ulinastatin on serum levels of tumor necrosis factor-α, P-selectin, and thrombin-antithrombin complex in young rats with sepsis]

Zhongguo Dang Dai Er Ke Za Zhi. 2017 Feb;19(2):237-241. doi: 10.7499/j.issn.1008-8830.2017.02.020.
[Article in Chinese]

Abstract

Objective: To investigate the effect of ulinastatin (UTI) for early drug intervention on the serum levels of tumor necrosis factor-α (TNF-α), P-selectin, and thrombin-antithrombin complex (TAT) in young rats with sepsis.

Methods: A total of 120 male rats aged 4 weeks were randomly divided into normal control group, sham-operation group, sepsis group, low-dose UTI group (50 000 U/kg), and high-dose UTI group (200 000 U/kg), with 24 rats in each group. Modified cecal ligation and puncture was performed to establish a rat model of sepsis, and the rats in the low- and high-dose UTI groups were given caudal vein injection of UTI after model establishment. ELISA was used to measure the serum levels of TNF-α, P-selectin, and TAT at 6, 12, and 24 hours after model establishment.

Results: The sepsis group had significant increases in the serum levels of TNF-α, P-selectin, and TAT at 6 hours, and the serum levels of TNF-α and TAT continued to increase by 24 hours (P<0.05); P-selectin reached the peak at 12 hours and decreased slightly at 24 hours (P<0.05). The UTI groups had similar change patterns in the levels of P-selectin and TAT as the sepsis group. The UTI groups had significant increases in the level of TNF-α at 6 hours, but gradually decreased over time. The changes in serum levels of TNF-α, P-selectin, and TAT in the UTI groups were significantly smaller than in the sepsis group (P<0.05). The high-dose UTI group had significantly smaller changes in serum levels of TNF-α, P-selectin, and TAT than the low-dose UTI group (P<0.05).

Conclusions: Early intervention with UTI can significantly improve coagulation function and inhibit the production of TNF-α, P-selectin, and TAT in young rats with sepsis. High-dose UTI has a significantly greater effect than low-dose UTI.

目的: 探讨使用乌司他丁(UTI)作为早期干预药物对脓毒症幼鼠血清肿瘤坏死因子-α(TNF-α)、P-选择素、凝血酶抗凝血酶复合物(TAT)水平的影响及意义。

方法: 将120只4周龄雄性大鼠随机分为正常对照组、假手术组、脓毒症组、低剂量UTI干预组(50000U/kg)和高剂量UTI干预组(200000U/kg),每组24只。采用改良的盲肠结扎穿孔法制作脓毒症大鼠模型,低剂量和高剂量UTI干预组在建模后分别尾静脉注射UTI。ELISA法测定6、12、24h时各组大鼠血清TNF-α、P-选择素、TAT水平。

结果: 脓毒症组大鼠血清TNF-α、TAT、P-选择素水平在6h时即出现显著升高,血清TNF-α、TAT水平至24h时仍呈持续升高状态(P < 0.05);P-选择素在12h时达到峰值,24h时出现回落(P < 0.05)。UTI干预组中,P-选择素和TAT水平变化趋势和脓毒症组相同,TNF-α水平在6h出现明显的增高,但随时间延长逐渐降低,且变化幅度均显著小于脓毒症组(P < 0.05);高剂量组变化幅度显著小于低剂量组(P < 0.05)。

结论: UTI早期干预对脓毒症幼鼠模型的凝血功能有明显的改善,能抑制TNF-α、P-选择素、TAT的生成,且高剂量组较低剂量组作用更显著。

MeSH terms

  • Animals
  • Antithrombin III
  • Glycoproteins / pharmacology*
  • Glycoproteins / therapeutic use
  • Male
  • P-Selectin / blood*
  • Peptide Hydrolases / blood*
  • Rats
  • Rats, Sprague-Dawley
  • Sepsis / blood
  • Sepsis / drug therapy*
  • Tumor Necrosis Factor-alpha / blood*

Substances

  • Glycoproteins
  • P-Selectin
  • Tumor Necrosis Factor-alpha
  • antithrombin III-protease complex
  • Antithrombin III
  • Peptide Hydrolases
  • urinastatin